Minerva Neurosciences (NERV) Misses Q2 EPS by 12c

Minerva Neurosciences (NASDAQ: NERV) reported Q2 EPS of ($1.09), $0.12 worse than the analyst estimate of ($0.97).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Lutnick Says 'we Trust Anthropic' - Axios
• Snowflake (SNOW) call put ratio 1.6 calls to 1 put into quarter results
• Hewlett Packard Enterprise (HPE) call put ratio 2.1 calls to 1 put into quarter results